Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Stoke Therapeutics Inc

Start price
Target price
Perf. (%)
€8.85
01.05.23
-
01.05.24
23.16%
02:15

buy
Stoke Therapeutics Inc

Start price
Target price
Perf. (%)
€8.85
28.04.23
€21.78
28.04.24
28.81%
29.04.24

Applied Therapeutics Inc

Start price
Target price
Perf. (%)
€5.80
19.02.24
-
19.02.25
-14.83%
15.04.24

Risky Investment
Stoke Therapeutics Inc

Start price
Target price
Perf. (%)
€5.80
17.03.24
€3.00
31.01.26
60.34%
25.03.24

Could be very worthwhile Investment >20% year
buy
Precision BioSciences Inc

Start price
Target price
Perf. (%)
€0.86
15.03.23
€16.09
15.03.24
-59.36%
16.03.24

buy
Stoke Therapeutics Inc

Start price
Target price
Perf. (%)
€8.60
08.03.23
€33.19
08.03.24
-20.93%
09.03.24

buy
Stoke Therapeutics Inc

Start price
Target price
Perf. (%)
€8.60
08.03.23
€23.71
08.03.24
-20.93%
09.03.24

buy
Applied Therapeutics Inc

Start price
Target price
Perf. (%)
€5.80
19.02.24
-
19.02.25
10.34%
03.03.24

Could be worthwhile Investment >10% per year
buy
Applied Therapeutics Inc

Start price
Target price
Perf. (%)
€2.67
24.12.23
€5.00
31.08.25
-16.32%
05.01.24

Could be very worthwhile Investment >20% year
buy
Applied Therapeutics Inc

Start price
Target price
Perf. (%)
€2.75
10.12.23
€3.50
31.03.26
-3.09%
24.12.23

Could be very worthwhile Investment >20% year
Personalis Inc

Start price
Target price
Perf. (%)
€1.91
16.05.23
-
16.05.24
-33.09%
11.12.23

Probably not worthwhile Investment
Precision BioSciences Inc

Start price
Target price
Perf. (%)
€5.87
09.01.22
-
09.01.23
-79.37%
10.01.23

Probably not worthwhile Investment
buy
Stoke Therapeutics Inc

Start price
Target price
Perf. (%)
€21.00
02.12.21
€28.00
02.12.22
-67.38%
03.12.22

Could be worthwhile Investment >10% per year
buy
Precision BioSciences Inc

Start price
Target price
Perf. (%)
€1.54
02.06.22
-
02.06.23
-16.63%
11.06.22

Risky Investment
buy
Immuron

Start price
Target price
Perf. (%)
€2.96
14.01.22
€0.000
14.01.23
18.92%
28.01.22

Could be very worthwhile Investment >20% year
Higher EBIT margin than peer group
Undervalued
Low dividend yield expected
buy
Immuron

Start price
Target price
Perf. (%)
€2.10
08.01.22
€4.00
08.01.23
39.05%
22.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Immuron

Start price
Target price
Perf. (%)
€14.90
09.06.20
-
10.06.20
-45.64%
10.06.20

buy
Ravenquest Biomed Inc.

Start price
Target price
Perf. (%)
€0.35
03.01.19
€0.80
30.04.19
16.86%
30.04.19